
Serpooshan & Bauser
Labs
for tissue manufacturing & analysis

video courtesy of Advanced Solutions
About Us
The Serpooshan Team uses a multidisciplinary approach to design and develop micro/nano-scale tissue engineering technologies with the ultimate goal of generating functional tissues and organs. Current projects in my lab include:
1) Bioengineering iPSC-based, functional cardiovascular tissue models, via 3D bioprinting technologies, as in vitro platforms to study human heart development and diseases;
2) Design and manufacturing novel patient-specific cardiac patch systems to regenerate damaged myocardium following ischemic heart injury;
3) 3D bioprinting of functional in vitro models of cortical organoids to study human brain development; and
4) Engineering highly tunable bioprinted models to study pediatric tumor growth, aggression, and response to therapies.

OUR LINES OF RESEARCH
Using state-of-the-art 3D bioprinting, perfusion bioreactor, and induced pluripotent stem cell technologies to engineer in vitro models of human heart development and diseases. Studying various cellular and environmental factors underlying congenital heart defects and their therapies.
Synthesis, characterization, and application of various nano/micro-scale biomaterials for diverse biomedical applications in vitro and in vivo. Examples include: magnetic nanoparticles for antibacterial and imaging applications, conductive nanorods to enhance cardiac tissue function, and nanostructured scaffolds.

Meet The Team

Vahid Serpooshan, PhD
Principal Investigator
Vahid Serpooshan did his BSc and MSc in Materials Science and Engineering at Sharif University (Tehran, Iran, 1998-2003) and his PhD in biomaterials and tissue engineering at McGill University (Montreal, Canada, 2007-2011). His PhD thesis research focused on the design and optimization of scaffolding biomaterials for bone tissue engineering applications. Following his PhD, Dr. Serpooshan worked for 7 years at Stanford University School of Medicine as Postdoctoral Fellow (Pediatric Cardiology) and Instructor (Stanford Cardiovascular Institute). At Stanford, Dr. Serpooshan's training and research were mainly centered on developing a new generation of engineered cardiac patch device to repair damaged heart tissue following myocardial infarction (heart attack). The engineered patch was successfully tested in mouse and pig models and is now in preparation for clinical trials. He also worked on enabling technologies for human-machine hybrid cardiac tissue, using 3D bioprinting to assemble complex arrays of interfaces between synthetic and biological materials. In 2018, Dr. Vahid Serpooshan joined Emory University and Georgia Institute of Tech as Assistant Professor of Biomedical Engineering and Pediatrics, where his multidisciplinary team is now working on a variety of 3D bioprinting-based tissue engineering and disease modeling projects.
Assistant Professor of Biomedical Engineering
and Pediatrics
Georgia Institute of Technology
Emory University School of Medicine
404.712.9717
Holly Bauser is an interventional pediatric cardiologist and physician scientist at Sibley Heart Center at Children’s Healthcare of Altanta. She completed her MD, PhD in 2009 at Indiana University. Dr. Bauser-Heaton focused on signaling mechanisms of nitric oxide in hypoxic conditions and continues to investigate the role of NO in endothelial function. As a clinician, she completed her training at Stanford University and joined faculty of Sibley Heart Center in 2016. Pulmonary artery disease and its management is the focus for Dr. Heaton both in the clinical arena and the lab. She is interested in developing new procedures via transcatheter (in the cardiac catheterization laboratory) technique for individuals with pulmonary artery disease. Additionally, she has interest in utilizing 3D bioprinting to create pulmonary artery constructs that have the ability to keep up with a patient’s somatic growth. She is very excited to join forces with the Serpooshan lab.

Holly Bauser, MD PhD
Assistant Professor
Pediatric Cardiologist

Sarah Rezapour, MD
Sarah Rezapour earned her MD degree from Tehran University of Medical Sciences (Tehran, Iran) in 2015. Following the completion of her degree, she embarked on a three-year practice in the field of medicine, gaining invaluable experience in patient care and medical practice. With a passion for delving deeper into the unmet needs in clinical settings, Dr. Rezapour transitioned to the research arena, joining the Tehran Research Institute of Gastrointestinal and Liver Diseases. Her project was directed toward unraveling the complex pathways involved in non-alcoholic steatohepatitis (NASH) progression and developing novel approaches for diagnosis and treatment. Sarah joined the Serpooshan lab in May 2023 as a postdoctoral research fellow. In her current role, she mainly focuses on Fontan-associated liver disease (FALD). Her project centers on biofabrication and in vitro culture strategies for constructing a vascular 3D model of the healthy human liver (hepatic sinusoid) vs. FALD tissue models.
Postdoctoral Fellow
Departments of Biomedical Engineering and Pediatrics
Emory University School of Medicine
Georgia Institute of Technology
Mehdi Salar Amoli received his BSc from Amirkabir University of Technology (Tehran Polytechnique, Iran), studying biomaterials and tissue engineering, and performing research on osteochondral tissue engineering. Next, he moved to London, where he continued studies in the field of biomaterials and tissue engineering at Imperial College London (ICL), conducting research at Dr. Molly Stevens group on nanoneedle based gene delivery techniques. Following his training at ICL, Mehdi moved to Belgium, where he received his PhD from KU Leuven. His doctoral research focused on development of bioinks for 3D bioprinting strategies aimed at regeneration of the dentoalveolar tissues. During his PhD, he focused on development of a range of stimuli-responsive biomaterials for bioprinting, sustained release delivery systems for incorporation of drugs and growth factors, as well as physical, mechanical and biological characterization of tissue engineered constructs. In 2023, Mehdi joined Serpooshan lab, where his main research focus is to develop in vitro disease models using bioprinting.
